These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11062969)

  • 21. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer.
    Holsinger FC; Funk E; Roberts DB; Diaz EM
    Head Neck; 2006 Sep; 28(9):779-84. PubMed ID: 16637055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
    Eisbruch A; Thornton AF; Urba S; Esclamado RM; Carroll WR; Bradford CR; Hazuka MB; Littles FJ; Strawderman M; Wolf GT
    J Clin Oncol; 1996 Aug; 14(8):2322-30. PubMed ID: 8708724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of induction chemotherapy in advanced carcinoma of the larynx].
    Yu SG
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(1):43-4, 60. PubMed ID: 7688976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
    Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
    Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organ preservation for advanced laryngeal carcinoma.
    Foote RL; Foote RT; Brown PD; Garces YI; Okuno SH; Strome SE
    Head Neck; 2006 Aug; 28(8):689-96. PubMed ID: 16619278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
    Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
    Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
    Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Postoperative radiotherapy in N0 laryngeal cancer].
    Maillard S; Jovenin N; Cauchois A; Froissart D; Merol JC; Chays A; Nguyen TD
    Cancer Radiother; 2005 Sep; 9(5):285-92. PubMed ID: 16168697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.